| 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 12.0 [1], 78.0 [2], 430.0 [3], 500.0 [4] |
| 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 9.8 [1], 100.0 [2] |
| N-[2-Methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide | IC50 | 1.5 [1], 2.0 [2] |
| Doramapimod | IC50 | 7.0 [1], 10000.0 [2] |
| Losmapimod | Ki | 25.12 [1] |
| N~3~-Cyclopropyl-N~4~'-(Cyclopropylmethyl)-6-Methylbiphenyl-3,4'-Dicarboxamide | IC50 | 1000.0 [1] |
| N~3~-Cyclopropyl-N~4~'-(Cyclopropylmethyl)-6-Methylbiphenyl-3,4'-Dicarboxamide | Ki | 24.0 [1] |
| 7-(1-Tert-butylpiperidin-4-yl)-1-(2,6-dichlorophenyl)-5-(2,4-difluorophenyl)quinolin-2-one | IC50 | 0.25 [1], 260.0 [2] |
| N-[5-(Cyclopropylcarbamoyl)-2-methylphenyl]-5-methyl-1-[3-(trifluoromethyl)pyridin-2-yl]pyrazole-4-carboxamide | IC50 | 4.0 [1] |
| N-[3-[4-(Cyclopropylmethylcarbamoyl)phenyl]-4-methylphenyl]-2-piperidin-1-ylpyridine-4-carboxamide | IC50 | 1000.0 [1], 10000.0 [2] |
| Tofacitinib | IC50 | 10000.0 [1] |
| Cyclohexanol, 4-(4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl)-, trans- | IC50 | 44.0 [1] |
| Neflamapimod | Ki | 220.0 [1] |
| Talmapimod | IC50 | 98.0 [1] |
| 3-(3-Bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide | Ki | 40.0 [1] |
| 3-(Dimethylamino)-N-(3-(4-hydroxybenzamido)-4-methylphenyl)benzamide | IC50 | 2000.0 [1] |
| 2-(Pyridin-4-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one | IC50 | 10000.0 [1] |
| Milciclib | IC50 | 10000.0 [1] |
| Benzamide, N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]- | IC50 | 200.0 [1] |
| Bms-582949 | IC50 | 62.0 [1] |
| 2-{4-[5-(4-Chlorophenyl)-4-Pyrimidin-4-Yl-1h-Pyrazol-3-Yl]piperidin-1-Yl}-2-Oxoethanol | IC50 | 3450.0 [1] |
| IKK-3 Inhibitor | IC50 | 15848.93 [1] |
| 6-[(6R)-2-(4-Fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one | IC50 | 36.0 [1] |
| PF-03715455 | IC50 | 23.0 [1] |
| N-(Furan-2-ylmethyl)-4-[(2-methylphenyl)carbonyl]-1H-pyrrole-2-carboxamide | IC50 | 6309.57 [1] |
| 4-[3-Methyl-2-piperidin-4-yl-5-[3-(trifluoromethyl)phenyl]imidazol-4-yl]-N-[(1S)-1-phenylethyl]pyridin-2-amine | IC50 | 0.1 [1] |
| N-Ethyl-4-[5-(methoxycarbamoyl)-2-methylanilino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide | IC50 | 15.0 [1] |
| 5-(2-Aminopyrimidin-4-yl)-2-phenyl-1H-pyrrole-3-carboxamide | IC50 | 10000.0 [1] |
| (7S)-2-(2-Aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one | IC50 | 4000.0 [1] |
| N-(Cyclopropylmethyl)-2'-Methyl-5'-(5-Methyl-1,3,4-Oxadiazol-2-Yl)biphenyl-4-Carboxamide | Ki | 440.0 [1] |
| Cyclapolin 9 | IC50 | 100000.0 [1] |
| 1-(2,6-Dichlorophenyl)-6-(2,4-difluorophenylthio)-1,2,3,4-tetrahydropyrido[3,2-d]pyrimidine-2-one | IC50 | 250.0 [1] |
| 6-Acetyl-8-cyclopentyl-5-methyl-2-(4-piperazin-1-yl-phenylamino)-8H-pyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 1-[4-(4-Pyridinylmethyl)phenyl]-3-(1-methyl-3-tert-butyl-1H-pyrazole-5-yl)urea | IC50 | 110.0 [1] |
| 3-[[5-Cyano-6-(cyclopentylamino)pyrimidin-4-yl]amino]-4-methyl-N-(1,2-oxazol-3-yl)benzamide | IC50 | 100.0 [1] |
| 3-[[4-[2,2-Dimethylpropyl(methyl)amino]-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazin-2-yl]amino]-N-methoxy-4-methylbenzamide | IC50 | 22.0 [1] |
| (13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dione | IC50 | 1000.0 [1] |
| N-Cyclopropyl-3-[1-(2,6-difluorophenyl)-7-methyl-6-oxopyrazolo[3,4-b]pyridin-5-yl]-4-methylbenzamide | Ki | 2.5 [1] |
| 1-(2,6-Dichlorophenyl)-6-(o-tolylthio)-3,4-dihydropyrido[3,2-d]pyrimidin-2(1H)-one | IC50 | 800.0 [1] |
| 1-(2,6-Dichlorophenyl)-6-(phenylthio)-3,4-dihydropyrido[3,2-d]pyrimidin-2(1H)-one | IC50 | 2370.0 [1] |
| 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamide | IC50 | 10000.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 50.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 4-[4-[(Z)-[3-[4-[3-(4-Methylpiperazin-1-yl)propoxy]phenyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]benzamide | IC50 | 30000.0 [1] |
| 2-Benzothiazolecarboxamide, 7-nitro-5-[(trifluoromethyl)thio]-, 3-oxide | IC50 | 100000.0 [1] |
| CID 9811100 | IC50 | 572.0 [1] |
| 2-(1-Methyl-4-hydroxy-4-piperidinyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)oxazole | IC50 | 2408.0 [1] |
| p38 MAP Kinase Inhibitor V | IC50 | 2320.0 [1] |
| Pyridine, 4-(2-(4-fluorophenyl)-5-(4-(methylsulfinyl)phenyl)-1H-pyrrol-3-yl)- | IC50 | 8.1 [1] |
| 1-[1-(3-Aminophenyl)-3-tert-butyl-1H-pyrazole-5-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 52.0 [1] |
| 3-[(6-Benzoyl-5-Methylpyrrolo[2,1-F][1,2,4]triazin-4-Yl)amino]-N-Cyclopropyl-4-Methylbenzamide | IC50 | 19.0 [1] |
| N-[(3-Methoxyphenyl)methyl]-4-[2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide | Ki | 160.0 [1] |
| 1-[4-[3-(4-Chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-5-yl]piperidin-1-yl]-2-methoxyethanone | IC50 | 3250.0 [1] |
| 6-(2-Chloro-4-fluorophenyl)sulfanyl-1-(2,6-dichlorophenyl)-3,4-dihydropyrido[3,2-d]pyrimidin-2-one | IC50 | 57.0 [1] |
| 4-[[2-[4-Chloro-3-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]anilino]-1,3-benzoxazol-5-yl]oxy]-N-methylpyridine-2-carboxamide | IC50 | 40000.0 [1] |
| 2-(2-Chloro-6-fluoro-phenyl)-N-(3-(4-fluorophenyl)-4-pyrimidin-4-yl-isoxazol-5-yl)acetamide | IC50 | 326.0 [1] |
| 3-[5-Chloro-4-[(2,4-difluorophenyl)methoxy]-6-oxopyrimidin-1-yl]-N-(2-hydroxyethyl)-4-methylbenzamide | IC50 | 249.0 [1] |
| 2-[3-(Methanesulfonamido)phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 10000.0 [1] |
| 2-[3-[3-(4-Methylpiperazin-1-yl)propoxy]phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 10000.0 [1] |
| 2-[3-(2-Chloro-N-[1-(2-chlorophenyl)-6-oxopyridazin-3-yl]-4-fluoroanilino)propyl]isoindole-1,3-dione | IC50 | 20.0 [1] |
| 2-[3-(2-Chloro-N-[1-(2-chlorophenyl)-6-oxopyridazin-3-yl]anilino)propyl]isoindole-1,3-dione | IC50 | 15.0 [1] |
| 3-[4-[(2,4-Difluorophenyl)methoxy]-5-ethyl-6-oxopyrimidin-1-yl]-N-(2-hydroxyethyl)-4-methylbenzamide | Ki | 6.0 [1] |
| 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2-methylpropyl)pyridine-3-carboxamide | Ki | 158.49 [1] |
| 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(cyclopropylmethyl)pyridine-3-carboxamide | Ki | 25.12 [1] |
| 4-(3-(4-Fluorophenyl)-5-(piperidin-3-yl)-1H-pyrazol-4-yl)pyridine | IC50 | 404.0 [1] |
| 1-(4-(3-(4-Chlorophenyl)-4-(pyridin-4-yl)-1H-pyrazol-5-yl)piperidin-1-yl)ethanone | IC50 | 3130.0 [1] |
| 1-[4-[3-(4-Chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-5-yl]piperidin-1-yl]-2-methoxyethanone | IC50 | 3450.0 [1] |
| 4-(5-(1-Methylpiperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)pyridine | IC50 | 164.0 [1] |
| 4-(3-(3-Chlorophenyl)-5-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl)pyridine | IC50 | 1050.0 [1] |
| 4-(3-(4-Fluorophenyl)-5-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridine | IC50 | 510.0 [1] |
| 4-(3-(4-Chlorophenyl)-5-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl)pyridine | IC50 | 2680.0 [1] |
| 4-(3-(4-Fluorophenyl)-5-(1-methylpiperidin-3-yl)-1H-pyrazol-4-yl)pyridine | IC50 | 2520.0 [1] |
| 4-(3-(4-Chlorophenyl)-5-(1-(methylsulfonyl)piperidin-4-yl)-1H-pyrazol-4-yl)pyridine | IC50 | 3530.0 [1] |
| 4-[3-(1-Acetylpiperidin-4-yl)-5-(4-chlorophenyl)-1H-pyrazol-4-yl]pyrimidine | IC50 | 3710.0 [1] |
| 1-(4-(3-(4-Fluorophenyl)-4-(pyridin-4-yl)-1H-pyrazol-5-yl)piperidin-1-yl)ethanone | IC50 | 1680.0 [1] |
| 4-(5-(1-Methylpiperidin-4-yl)-3-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)pyridine | IC50 | 3770.0 [1] |
| 1-[4-[3-(4-Chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-5-yl]piperidin-1-yl]-2-(dimethylamino)ethanone | IC50 | 6720.0 [1] |
| 4-(3-(4-Chlorophenyl)-5-(1-(2-methoxyethyl)piperidin-4-yl)-1H-pyrazol-4-yl)pyridine | IC50 | 6720.0 [1] |
| 4-(3-(4-Fluorophenyl)-5-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl)pyridine | IC50 | 1960.0 [1] |
| N,4-Dimethyl-3-[[6-(methylamino)-1-phenylpyrazolo[3,4-d]pyrimidin-4-yl]amino]benzamide | IC50 | 12.0 [1] |
| 2-(2-Chlorophenyl)-6-[(2-chlorophenyl)amino]-2,3-dihydropyridazin-3-one | IC50 | 990.0 [1] |
| 2-(2-Chlorophenyl)-6-[(2-methylphenyl)amino]-2,3-dihydropyridazin-3-one | IC50 | 450.0 [1] |
| 2-(2-Chlorophenyl)-6-[(2-methoxyphenyl)amino]-2,3-dihydropyridazin-3-one | IC50 | 920.0 [1] |
| 2-(2-Chlorophenyl)-6-[(2-fluorophenyl)sulfanyl]-2,3-dihydropyridazin-3-one | IC50 | 450.0 [1] |
| 2-(4-Chloro-2-methylphenyl)-6-[(2,4-difluorophenyl)sulfanyl]-2,3-dihydropyridazin-3-one | IC50 | 850.0 [1] |
| 6-[(2-Chloro-4-fluorophenyl)(2-hydroxyethyl)amino]-2-(2-chlorophenyl)-2,3-dihydropyridazin-3-one | IC50 | 135.0 [1] |
| 6-[(3-Aminopropyl)(2-chlorophenyl)amino]-2-(2-chlorophenyl)-2,3-dihydropyridazin-3-one | IC50 | 211.0 [1] |
| 2-(2-Chlorophenyl)-6-[2-chloro-N-[3-[(2,3,4-trimethoxyphenyl)methylamino]propyl]anilino]pyridazin-3-one | IC50 | 600.0 [1] |
| 2-Amino-N-[3-(2-chloro-N-[1-(2-chlorophenyl)-6-oxopyridazin-3-yl]anilino)propyl]acetamide | IC50 | 41.0 [1] |
| N-[3-(2-Chloro-N-[1-(2-chlorophenyl)-6-oxopyridazin-3-yl]anilino)propyl]-2-(methylamino)acetamide | IC50 | 29.0 [1] |
| N-[3-(2-Chloro-N-[1-(2-chlorophenyl)-6-oxopyridazin-3-yl]anilino)propyl]piperidine-4-carboxamide | IC50 | 29.0 [1] |
| N-[3-(2-Chloro-N-[1-(2-chlorophenyl)-6-oxopyridazin-3-yl]anilino)propyl]-4-(trifluoromethyl)cyclohexane-1-carboxamide | IC50 | 2.0 [1] |
| 5-(4-Chlorophenyl)-N-[5-(cyclopropylcarbamoyl)-2-methylphenyl]thiophene-2-carboxamide | IC50 | 270.0 [1] |
| 4-(2-Chloro-4-fluorophenyl)-8-(2,6-dichlorophenyl)-7-oxido-1,7-naphthyridin-7-ium | IC50 | 10000.0 [1] |
| 5-(2-Chlorophenyl)-N-[5-(Cyclopropylcarbamoyl)-2-Methylphenyl]thiophene-2-Carboxamide | IC50 | 265.0 [1] |
| N-[5-(Cyclopropylcarbamoyl)-2-methylphenyl]-5-[4-(morpholine-4-carbonyl)phenyl]thiophene-2-carboxamide | IC50 | 81.0 [1] |
| N,6-Dimethyl-7-(1-((S)-3-methylmorpholino)phthalazin-6-yl)-benzo[d]isoxazol-3-amine | Ki | 1.8 [1] |
| 3,5-Dichloro-N-[2-(dimethylamino)ethyl]-4-[6-(4-fluorophenyl)sulfanyl-2-oxo-3,4-dihydropyrido[3,2-d]pyrimidin-1-yl]benzamide | IC50 | 1230.0 [1] |
| 1-(2-Chloro-6-ethylphenyl)-6-(4-fluorophenyl)sulfanyl-3,4-dihydropyrido[3,2-d]pyrimidin-2-one | IC50 | 200.0 [1] |
| Methyl 3-chloro-4-[6-(4-fluorophenyl)sulfanyl-2-oxo-3,4-dihydropyrido[3,2-d]pyrimidin-1-yl]-5-methylbenzoate | IC50 | 250.0 [1] |